Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | PPM1B | O75688 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 2/20 | 0.36 |
| ▸ | AHCY | P23526 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5608420 | 0.95 | EPHX2 (0.40) | PPM1BPTPN1PPP1CCEPHX2NAAA | |
| SCHEMBL5609289 | 0.94 | NAAA (0.40) | EPHX2NAAA | |
| SCHEMBL5608930 | 0.91 | PPM1B (0.45) | ALDH1A1PPM1BPTPN1PPP1CCNAAA | |
| SCHEMBL5608908 | 0.84 | ALDH1A1 (0.43) | ALDH1A1PPM1BPTPN1PPP1CCATM | |
| SCHEMBL8633605 | 0.75 | ALDH1A1 (0.50) | ALDH1A1ATMEPHX2NAAA | |
| SCHEMBL453054 | 0.75 | ALDH1A1 (0.50) | ALDH1A1ATMEPHX2NAAA | |
| SCHEMBL10103543 | 0.75 | ALDH1A1 (0.50) | ALDH1A1ATMEPHX2NAAA | |
| SCHEMBL5608543 | 0.75 | SMN1; SMN2 (0.39) | ALDH1A1PPM1BPTPN1PPP1CCPOLB | |
| Hydrochloric Acid SCHEMBL28237612 | 0.74 | ALDH1A1 (0.49) | ALDH1A1ATMEPHX2NAAA | |
| SCHEMBL9566682 | 0.73 | ALDH1A1 (0.48) | ALDH1A1PPM1BPTPN1PPP1CCATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7169944-B2 | Optically active epoxy compounds and processes for their production | TOSOH CORPORATION (JP) | 2007-01-30 | — | — | US | disclosed |
| US-20040063979-A1 | Optically active epoxy compounds and processes for their production | TOSOH CORPORATION (JP) | 2004-04-01 | — | — | US | disclosed |
| EP-1403260-A2 | Optically active epoxy compounds and processes for their production | Tosoh Corporation (JP) | 2004-03-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063979-A1 | Optically active epoxy compounds and processes for their production | CYP51A1, CYP11B1, PTGES | ALDH1A1 349/4885PPM1B 3607/4885PTPN1 4531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.